| 1 |
34800879 | Novel combination therapy of prostate cancer cells with arsenic trioxide and flutamide: An in-vitro study. | 2022 Feb |
1 |
| 2 |
35487055 | Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach. | 2022 Jun |
1 |
| 3 |
33357454 | Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site. | 2021 Feb 8 |
3 |
| 4 |
33508133 | Broad-spectrum rescue compounds for structural p53 mutations: perspective on 'Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site'. | 2021 May 7 |
2 |
| 5 |
33561393 | Arsenic and an Old Place: Rescuing p53 Mutants in Cancer. | 2021 Feb 8 |
1 |
| 6 |
34255251 | Effects of co-administration of arsenic trioxide and Schiff base oxovanadium complex on the induction of apoptosis in acute promyelocytic leukemia cells. | 2021 Oct |
1 |
| 7 |
34476069 | Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin. | 2021 Aug 18 |
3 |
| 8 |
34880920 | Exploring the Mechanisms of Arsenic Trioxide (Pishuang) in Hepatocellular Carcinoma Based on Network Pharmacology. | 2021 |
1 |
| 9 |
32017938 | Long non-coding RNA ROR confers arsenic trioxide resistance to HepG2 cells by inhibiting p53 expression. | 2020 Apr 5 |
8 |
| 10 |
29535630 | Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology. | 2018 |
1 |
| 11 |
29910624 | Effects of the combination of As2O3 and AZT on proliferation inhibition and apoptosis induction of hepatoma HepG2 cells following silencing of Egr-1. | 2018 |
1 |
| 12 |
29164574 | Mechanism of As2O3 induces apoptosis of glioma U87 cells. | 2017 Nov |
1 |
| 13 |
26440706 | p53-based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study. | 2016 Jan |
1 |
| 14 |
27638049 | ATF4 regulates arsenic trioxide-mediated NADPH oxidase, ER-mitochondrial crosstalk and apoptosis. | 2016 Nov 1 |
2 |
| 15 |
25444910 | Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma. | 2015 Jan 28 |
1 |
| 16 |
23255470 | Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic. | 2014 May |
2 |
| 17 |
24399651 | The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma. | 2014 May |
9 |
| 18 |
24738333 | Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells. | 2014 Feb |
1 |
| 19 |
24833880 | Arsenic trioxide induces apoptosis of human gastrointestinal cancer cells. | 2014 May 14 |
1 |
| 20 |
24884809 | Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma. | 2014 May 31 |
4 |
| 21 |
24927258 | Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade. | 2014 |
9 |
| 22 |
25116336 | Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase. | 2014 |
6 |
| 23 |
25485499 | Proteasome inhibitors suppress the protein expression of mutant p53. | 2014 |
1 |
| 24 |
26579413 | ETME, a novel β-elemene derivative, synergizes with arsenic trioxide in inducing apoptosis and cell cycle arrest in hepatocarcinoma cells via a p53-dependent pathway. | 2014 Dec |
1 |
| 25 |
23337567 | Osteoblasts survive the arsenic trioxide treatment by activation of ATM-mediated pathway. | 2013 Apr 1 |
1 |
| 26 |
24004656 | Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells. | 2013 Nov |
1 |
| 27 |
24211095 | Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway. | 2013 Dec |
4 |
| 28 |
21308489 | Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase. | 2012 Jun |
3 |
| 29 |
21454520 | Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression. | 2011 May 20 |
2 |
| 30 |
21792014 | YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide. | 2011 Aug |
1 |
| 31 |
20377131 | Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line. | 2010 |
1 |
| 32 |
20953137 | Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2. | 2010 Dec 1 |
4 |
| 33 |
19444595 | Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide. | 2009 Nov |
1 |
| 34 |
19457607 | Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation. | 2009 Nov 1 |
2 |
| 35 |
19587434 | [Effect of arsenic trioxide combined with adriamycin on the proliferation and apoptosis of human lymphoma cells]. | 2009 Jun |
1 |
| 36 |
17530438 | Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. | 2008 Sep |
1 |
| 37 |
18482988 | Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase. | 2008 Jul 4 |
8 |
| 38 |
18583568 | Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways. | 2008 Sep 15 |
3 |
| 39 |
18668508 | Requirement of a functional spindle checkpoint for arsenite-induced apoptosis. | 2008 Oct 15 |
2 |
| 40 |
17332940 | Arsenic trioxide induces p53-dependent apoptotic signals in myeloma cells with SiRNA-silenced p53: MAP kinase pathway is preferentially activated in cells expressing inactivated p53. | 2007 Apr |
3 |
| 41 |
17487067 | Differential protection and transactivation of P53, P21, Bcl2, PCNA, cyclin G, and MDM2 genes in rat liver and the HepG2 cell line upon exposure to pifithrin. | 2007 |
1 |
| 42 |
18167198 | Effects of HBV X gene and arsenic trioxide on the expression of p53 in cultured HepG2 cells. | 2007 Dec 20 |
9 |
| 43 |
16283431 | Opposite effect of ERK1/2 and JNK on p53-independent p21WAF1/CIP1 activation involved in the arsenic trioxide-induced human epidermoid carcinoma A431 cellular cytotoxicity. | 2006 Jan |
1 |
| 44 |
16467208 | MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis. | 2006 Jun 1 |
1 |
| 45 |
16646077 | Clinically tolerable concentrations of arsenic trioxide induce p53-independent cell death and repress NF-kappa B activation in Ewing sarcoma cells. | 2006 Oct 1 |
1 |
| 46 |
16891316 | ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis. | 2006 Sep 29 |
2 |
| 47 |
16950207 | Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin. | 2006 Nov 15 |
3 |
| 48 |
17064470 | [Study of effects of HBV X gene and As2O3 on expression and activity of p53 in HepG2 cells with shRNA]. | 2006 Oct |
1 |
| 49 |
15904916 | Up-regulation of telomere-binding TRF1, TRF2 related to reactive oxygen species induced by As(2)O(3) in MGC-803 cells. | 2005 May 23 |
1 |
| 50 |
14726646 | Arsenic trioxide and paclitaxel induce apoptosis by different mechanisms. | 2004 Mar |
1 |